FGFR2 and neoplasm: Liquid biopsies measuring FGFR2 amplification or splice variants via circulating tumor DNA (ctDNA) and cell-free RNA (cfRNA) may broaden sampling yet remain technically constrained in resolving isoform-level heterogeneity.160